This document provides the draft programme for the 13th International Review of Bipolar Disorders conference taking place from March 18-20, 2013 in Seville, Spain. The programme includes keynote speeches, debates, parallel sessions, and oral presentations on topics related to bipolar disorders, including categories and dimensions of bipolarity, changing clinical concepts, and understanding disease progression. Presentations will cover temperament, neurobiology, cognition, treatment approaches, comorbidities, and more. The conference is organized by the European Bipolar Forum and sponsored by various pharmaceutical companies.
Lista com as 50 páginas com mais curtidas por usuários residentes no Pará do Facebook, lembrando que a ferramenta só leva em consideração usuários com mais de 18 anos e que acessaram o Facebook pelo menos uma vez nos últimos 30 dias.
Lista com as 50 páginas com mais curtidas por usuários residentes no Pará do Facebook, lembrando que a ferramenta só leva em consideração usuários com mais de 18 anos e que acessaram o Facebook pelo menos uma vez nos últimos 30 dias.
A biopsychosocial approach to stroke physiotherapy. This is a move to integrate the personal and environmental factors to the standing biomedical understanding of the disease for a tailor-made treatment.
Foresight in medicine: research induced society changes in the next decadeCaroline McClain
The 2013 symposium hosts a debate among scientists, doctors, policy makers and epistemologists aimed at identifying forthcoming medical research developments likely to impact on society in the next ten years.
Personalized (or precision) medicine is the changing paradigm and will reshape service contents and delivery modalities. The main clinical areas where major progress is expected are cancer, neurodegenerative disorders, chronic obstructive pulmonary diseases, rare diseases, dysmetabolic and endocrine system related diseases.
Progress in imaging, the application of nanotechnologies, the use of robotics, wired environments and telematics, portable devices, stem cells and new materials will make personalized medicine feasible and affordable. At the same time, epigenetics, pharmacogenomics, synthetic biology will contribute extensively to change further
medicine and its social aspects, and will need to be regulated by a new bioethical approach.
In collaboration with Georgetown University Italian Research Institute and ISSNAF.
As part of "Anno Della Cultura Italiana" or Year of Italian Culture in the U.S.
A biopsychosocial approach to stroke physiotherapy. This is a move to integrate the personal and environmental factors to the standing biomedical understanding of the disease for a tailor-made treatment.
Foresight in medicine: research induced society changes in the next decadeCaroline McClain
The 2013 symposium hosts a debate among scientists, doctors, policy makers and epistemologists aimed at identifying forthcoming medical research developments likely to impact on society in the next ten years.
Personalized (or precision) medicine is the changing paradigm and will reshape service contents and delivery modalities. The main clinical areas where major progress is expected are cancer, neurodegenerative disorders, chronic obstructive pulmonary diseases, rare diseases, dysmetabolic and endocrine system related diseases.
Progress in imaging, the application of nanotechnologies, the use of robotics, wired environments and telematics, portable devices, stem cells and new materials will make personalized medicine feasible and affordable. At the same time, epigenetics, pharmacogenomics, synthetic biology will contribute extensively to change further
medicine and its social aspects, and will need to be regulated by a new bioethical approach.
In collaboration with Georgetown University Italian Research Institute and ISSNAF.
As part of "Anno Della Cultura Italiana" or Year of Italian Culture in the U.S.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
Programa International Review of Bipolar Disorders Sevilla 2013
1. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 1 - Monday 18 March 2013 - Draft Programme
Theme: Categories & Dimensions -
Temperament, Spectrum and Associated Issues
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
09.00 Registration Opens (open for duration of conference)
Morning plenary sessions - Gran Salón Andalucía
09.15 Pre-conference Workshop: Introduction to Impulsivity
(in association with International Society for Research on Impulsivity)
Chair: Prof A Swann (US)
Impulsivity: Its measurement and its relationship to clinical phenomena
Prof A Swann (US)
Brain mechanisms of impulsivity and relationships to risky behaviour
Dr L Mason (UK)/Prof R Rogers (UK)
Practical aspects: Relationships to outcome, nonpharmacological and pharmacological treatments
Prof J Scott (UK)/Prof E Jimenez (ES)
11.15 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
11.45 IRBD 2013 Welcome and Introduction
Conference Chairman: Prof E Vieta (ES)
EBF Director: Mr R Pendleton (UK)
12.00 MS1: European Bipolar Forum: Affective temperament
Chair: Prof J Angst (CH)
Bipolarity in patients with borderline personality disorders: What is
specific and non-specific?
Prof G Perugi (IT)
Borderline in Cyclothymia, the role of irritable temperament
Dr E Hantouche (FR)
Prediction of suicidality in the community: The role of temperament
Prof E Karam (LB)
13.30 Lunch and Poster session (PO1) - Vestíbulo, Salón Malaga & Salón Marbella
14.30 PS1: Temperaments as mediators of suicide risk, PS2: Evolutionary aspects of bipolar disorders
hopelessness and psychopathology in bipolar and affective temperaments (Salón Alanda)
disorders (Gran Salón Andalucía) Dr X Gonda (HU)
Prof M Pompili (IT)
A Cortex Congress Conference PROGRAMME CO-CHAIRS
2. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 1 - Monday 18 March 2013 (Cont’d)
Theme: Categories & Dimensions - Temperament, Spectrum and Associated Issues
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
15.00 MS2: Neurobiological markers in MS3: Youth temperament and affective disorders
bipolar illness (Gran Salón Andalucía) (Salón Alanda)
Chair: Prof J K Rybakowski (PL) Chair: Prof M L Figueira (PT)
Biological markers of staging in bipolar illness Youth suicide attempts
Prof F Kapczinski (BR) Prof M L Figueira (PT)
GSK-3beta and beta-catenin in the postmortem The prodromal phase of bipolar disorder
brain of bipolar and schizophrenic subjects Prof G Faedda (US)
Prof G Pandey (US) Advances in assessment: fast and frugal
The HPA Axis and cognition in bipolar disorder methods of detection without over diagnosis
Prof A Young (UK) Prof E Youngstrom (US)
Clinical and biological markers of lithium response Delayed sleep offset and other markers of circadian
Prof J K Rybakowski (PL) rhythm disruption are common in young people with
emerging mood disorders
Prof I Hickie (AU)
17.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
17.30 MS4: Clinical staging: Understanding the evolu- MS5: The impact of co-morbidities on Bipolar
tion of bipolar disorders and defining treat- Chair: Prof G Perugi (IT) (Salón Alanda)
ments for at risk and early onset cases
Chair: Prof J Scott (UK) (Gran Salón Andalucía) Obesity & bipolar disorder
Prof A Tortorella (IT)
Clinical staging models for bipolar disorders:
Understanding different approaches to staging Affective temperament and
Prof J Scott (UK) smoking
Prof Z Rihmer (HU)
An evidence map of psychosocial interventions for
‘at risk’, first episode and early onset bipolar The impact of comorbidities of bipolar disorder -
disorders Alcohol, temperament and bipolar disorder
Dr M Vallarino (IT) Prof A Erfurth (AT)
What do offspring studies teach us about clinical Comorbidity and functioning
staging models for bipolar disorders? Dr L Gutierrez-Rojas (ES)
Prof A Duffy (CA)
Bipolar spectrum and heroin
Examining the evidence for pharmacological addiction - tendency to abuse or self-medication?
treatments in recent onset bipolar disorder? Prof I Maremmani (IT)
Prof F Bellivier (FR)
19.30 DB1: What comes first? High level of impulsiveness or mood instability?
Chair: Prof K Fountoulakis (GR) (Gran Salón Andalucía)
Argument for impulsiveness
Prof A Swann (US)
Argument for mood instability
Prof Z Rihmer (HU)
Discussion: Prof K Fountoulakis (GR)
20.30 CLOSE of Day 1 and Welcome Reception
21.30 EBF International Scientific Advisory Committee Dinner
IRBD 2014 Programming meeting
A Cortex Congress Conference PROGRAMME CO-CHAIRS
3. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 2 - Tuesday 19 March 2013 - Draft Programme
Theme: Changing Clinical Concepts -
Re-definitions, New Treatments & Evolution
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
09.00 MS6: Cognition and Bipolar Disorders PS3: Trauma and bipolar disorder
Chair: Prof A Erfurth (AT) (Gran Salón Andalucía) Chair: Dr G Faedda (US)
Dr B Amann (ES)
The assessment and treatment of cognitive
deficits in bipolar disorder
Prof A Martinez-Aran (ES) PS4: Antidepressant use in Bipolar disorder II
The burden of cognitive dysfunction Chair: Dr G Faedda (US)
Prof G Sachs (AT) Dr J Undurraga (ES)
10.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
10.30 The Paradigm Shift in Bipolar I Disorder (Lundbeck sponsored symposium)
Chair - Prof E Vieta (ES) (Gran Salón Andalucía)
Introducing clinically relevant subtypes in DSM-V
Prof J van Os (NL)
Managing the core manic symptoms and the depressive features in manic bipolar I
Prof H Grunze (UK)
Customised treatment of bipolar I patients
Prof A Young (UK)
Assertive treatment of bipolar I (remission and beyond)
Prof E Vieta (ES)
General discussion
12.30 KN1: Bipolar and anxiety disorders: Comorbidity and validity of episode length
Prof J Angst (CH) (Gran Salón Andalucía)
13.00 Lunch and Poster session (PO2) - Vestíbulo, Salón Malaga & Salón Marbella
Afternoon plenary sessions - Gran Salón Andalucía
14.00 Patient and physician perspectives in bipolar disorder (AstraZeneca sponsored symposium)
Chair - Prof E Vieta (ES)
Treatment approaches in bipolar disorder
Prof A Young (UK)
Evidence and issues in the real world
Prof E Vieta (ES)
Maximising patient outcomes: Bringing together perspectives
Prof H McAllister-Williams (UK)
Panel discussion
A Cortex Congress Conference PROGRAMME CO-CHAIRS
4. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 2 - Tuesday 19 March 2013 - Draft Programme - Cont
Theme: Changing Clinical Concepts -
Re-definitions, New Treatments & Evolution
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
16.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
16.30 MS7: Recent advances in the short-term treatment of bipolar depression
Chair: Prof J Calabrese (US)
Morbidity and mortality associated with bipolar depression
Prof T Ketter (US)
Short-term studies in bipolar depression using adjunctive designs
Prof J Calabrese (US)
Linking neurotransmitter receptors to novel mechanisms of therapeutic action and side-effect profiles
Dr J Goikolea (ES)
18.00 MS8: Understanding the long-term perspective and options to help achieve long-term remission
Chair: Prof K Fountoulakis (GR)
Bipolar depression and interepisodal symptomatology
Prof A González-Pinto (ES)
Psychosocial interventions and physical care
Dr C Torrent (ES)
Refractoriness in bipolar disorder: Definitions and evidence-based treatment
Prof K Fountoulakis (GR)
19.30 CLOSE Day 2
20.30 Gala Dinner and Presentation of EBF Lifetime Achievement Award
A Cortex Congress Conference PROGRAMME CO-CHAIRS
5. The 13th International Review of
Bipolar Disorders
18 - 20 March 2013 NH Hotel Convention Centre, Seville, Spain
www.irbd.org
Day 3 - Wednesday 20 March 2013 - Draft Programme
Theme: Understanding Disease Progression -
Advanced Diagnostics & Care, Today & Tomorrow
Key: MS = Multiple, KN = Keynote, DB = Debate, OP = Oral Platform, PO = Posters, PS = Parallel Session
Morning plenary sessions - Gran Salón Andalucía
09.00 KN2: Functional imaging abnormality in bipolar disorder: What changes and what doesn’t change
across phases
Chair:
Dr P McKenna (ES)
09.30 KN3: Pharmacogenetics and personalized pharmacology of bipolar disorder
Chair: Prof J Del Tito (US)
Prof J Kelsoe (US)
10.00 MS9: Marking a border between bipolar and unipolar disorders
Chair: Dr A Murru (ES)
Risks and advantages of the use of antidepressants in bipolar depression
Prof L Tondo (IT)
Unipolar and bipolar schizoaffective disorders: diagnostic residuals or clinical entities?
Dr A Murru (ES)
11.00 Refreshments - Vestíbulo, Salón Malaga & Salón Marbella
11.30 PS5: When first line treatment will not suffice OP: Oral Platform sessions
Chair: Prof J Cookson (UK) Chair:
(Gran Salón Andalucía) (Salón Alanda)
The use of residential treatment for children and Affective temperaments in the Tunisian general
adolescents with bipolar disorder and psychological Population - Dr R Zaibi Jomli
resistance to it Mixed hypomania with psychotic features congruent
Prof R Bush (US) for the depressed phase - Prof S Dilsaver
Let’s face it: facial emotion processing is impaired in
The severe part of the bipolar II spectrum: Border-
bipolar disorder - Miss T Van Rheenen
line personality and more persistant
Mental imagery: an emotional amplifier for bipolar dis-
psychopathology
order? - Dr R MK Ng
Prof J Deltito (US)
Proposals for new paths to bipolarity, mixity,
Factors associated with adherence to medication in fibromyalgia and migraine - Dr G Treviranus
a French cohort (FACE-BD) of bipolar patients Could glutamate spectroscopy differentiate bipolar
Prof R Belzeaux (FR) depression from unipolar? - Dr M Taylor
Prestige and bipolarity: An evolutionary perspective -
Dr J Le Bas
13.00 KN4: Depot antipsychotic medication in bipolar disorder
Prof J Cookson (UK) (Gran Salón Andalucía)
13.30 Closing Address and Close of Conference
A Cortex Congress Conference PROGRAMME CO-CHAIRS
